# A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

> **NCT07158151** · PHASE2 · COMPLETED · sponsor: **Reistone Biopharma Company Limited** · enrollment: 168 (actual)

## Conditions studied

- Atopic Dermatitis of Adults

## Interventions

- **DRUG:** RSS0393 ointment
- **DRUG:** RSS0393 ointment
- **DRUG:** RSS0393 ointment
- **DRUG:** RSS0393 ointment

## Key facts

- **NCT ID:** NCT07158151
- **Lead sponsor:** Reistone Biopharma Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-25
- **Primary completion:** 2026-04-10
- **Final completion:** 2026-04-10
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07158151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07158151, "A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07158151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*